Palatin Presents Initial Dry Eye Disease Phase 3 Clinical Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference

– Poster data demonstrates PL9643 positive effects on signs and symptoms of dry eye disease – Consistent clinical efficacy across multiple signs and symptoms of dry eye along with excellent safety and tolerability build a differentiating product profile – Melody-1 Phase 3 clinical study…